Antimicrobial susceptibility of Moraxella bovis

Veterinary Microbiology

Volumn 61, Issue 4, 1998, Pages 305-309

  Shryock, Thomas R ^a   White, Donald W ^a   Werner, Carolyn S ^b  

^a Animal Science Research   (United States)

^b CAVL Inc   (United States)

Author keywords

Antibiotics; Infectious bovine keratoconjunctivitis; Moraxella bovis; Pinkeye

Indexed keywords

AMPICILLIN; CEFTIOFUR; ERYTHROMYCIN; GENTAMICIN; OXYTETRACYCLINE; TILMICOSIN; TYLOSIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; DRUG EFFICACY; GRAM NEGATIVE BACTERIUM; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA BOVIS; NONHUMAN; TISSUE INJURY;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHALOSPORINS; ERYTHROMYCIN; GENTAMICINS; KERATOCONJUNCTIVITIS, INFECTIOUS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MORAXELLA (MORAXELLA) BOVIS; NEISSERIACEAE INFECTIONS; OXYTETRACYCLINE; TYLOSIN;

EID: 0032522191     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(98)00191-6     Document Type: Article

References (13)

1. Edmondson A., George L.W., Farver T.B. Survival analysis for evaluation of corneal ulcer healing times in calves with naturally acquired infectious bovine keratoconjunctivitis. Am. J. Vet. Res. 50(6):1989;838-844.
2. George, L.W., 1990a. Antibiotic treatment of infectious bovine keratoconjunctivitis. Cornell Vet. 80, 229-235.
3. George, L.W., 1990b. Managing bovine pinkeye. Calif. Agr. 44(2), 11-12.
4. George L.W., Smith J.A., Kaswan R. Distribution of oxytetracycline into ocular tissues and tears of calves. J. Vet. Pharm. Therap. 8:1985;47-54.
5. George L., Mihalyi J., Edmondson A., Daigneault J., Kagonyera G., Willits N., Lucas M. Topically applied furazolidone or parenterally administered oxytetracycline for the treatment of infectious bovine keratoconjunctivitis. J. Am. Vet. Med. Assoc. 192:1988;1415-1422.
6. The Merck Veterinary Manual. 1991. A handbook of diagnosis, therapy, and disease prevention and control for the veterinarian. 7th edn. Merck, Rahway, NJ, USA.
7. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition; Approved Standard. NCCLS document M7-A3 (ISBN 1-56238-209-8). NCCLS, 771 East Lancaster Avenue, Villanova, PA 19085, USA, 1993.
8. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria isolated from animals; Proposed Standard. NCCLS document M31-P (ISBN 1-56238-258-6). NCCLS, 771 East Lancaster Avenue, Villanova, PA 19085, USA, 1994.
9. Ose E.E. In vitro antibacterial properties of EL-870: a new semisynthetic macrolide antibiotic. J. Antibiot. 40:1987;190-194.
10. Punch P.I., Costa N.D., Chambers E.D., Slatter D.H., Wilcox G.E. Plasma and tear concentrations of antibiotic administered parenterally to cattle. Res. Vet. Sci. 39:1985;179-187.
11. Shryock T.R., White D.W., Werner C., Staples M. Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin. J. Clin. Microbiol. 33:1995;331-335.
12. Traub W.H., Leonhard B. Susceptibility of Moraxella catarrhalis to 21 antimicrobial drugs: validity of current NCCLS criteria for the interpretation of agar disk diffusion antibiograms. Chemother. 43:1997;159-167.
13. Webber J.J., Fales W.H., Selby L.A. Antimicrobial susceptibility of Moraxella bovis determined by agar disk diffusion and broth micro-dilution. Antimicrob. Agents Chemother. 21:1982;554-557.